Back to basics: striving to stall Parkinson ’s disease progression

First described 200 years ago, Parkinson ’s disease remains without a cure. After many failed clinical trials, researchers are getting back to basics to try to gain a better understanding of the challenges, and a new generation of treatment ideas are now in clinical trials, some of which aim to stall progression of the disease.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research